Overview

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
A phase 2 study with the primary objective of testing treatment compliance of Upfront Intensity Modulated Proton Beam Therapy (IMPT) and Concurrent Chemotherapy (UPPROACH) for Post-operative Treatment in Loco-regionally Advanced Endometrial Cancer is non-inferior to the historic compliance rate of the chemoradiation arm of GOG 258 study
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland, Baltimore
Treatments:
Carboplatin
Paclitaxel